Professor Joel Litman called the 2008 and 2020 meltdowns. But for the first time ever, he's explaining how a domino effect was just triggered that's going to directly impact dozens of America's favorite public companies... Right now, he's tracking more than 200 companies in his system that could crash before the end of 2025. And he's sharing two popular names he believes could fall the most for FREE. Learn more here.
Registration is closing very soon for the 2025 Stansbery Conference & Alliance Meeting. Don't miss the chance to meet and see – LIVE – all your favorite editors and guests, including Dr. David "Doc" Eifrig, Porter Stansberry, Marc Chaikin, Joel Litman, Dan Ferris, Eric Wade, and more... Plus, experience an incredible speaker lineup of Kara Swisher, Josh Brown, Peter Diamandis, and many others. See details and get your ticket here.
AI at Work Isn't What You'd Expect Right Now
I'm talking about an MIT report called "The GenAI Divide: State of AI in Business 2025." It covers the results of interviews, surveys, and analysis of more than 300 publicly disclosed AI initiatives.
And a big takeaway from the report might sound surprising...
Ninety-five percent of organizations that invested in "GenAI" tools made no returns on the investments.
You might have seen the term "GenAI" before. It's an abbreviation for "generative AI." And it refers to AI that creates new and unique data from the data sets that the technology trained on.
The MIT report analyzes data from GenAI and general-purpose large language models ("LLM") – AI tools that users can "talk" to for information. Models like ChatGPT and Claude are examples of LLMs.
Overall, the report states that organizations have higher rates of successful use with LLMs than with GenAI tools.
Users were enthusiastic about using GenAI programs for themselves at first. But these programs failed to deliver reliable, usable results.
According to the report, these GenAI tools also had poor user experiences. And users often couldn't trust the product it spat out.
Users were also unwilling to change their routines to add GenAI into their workflow.
I don't blame them, though. I wouldn't want to change a functional routine to a less-efficient one.
However, the MIT report states that employees saw LLMs in a better light...
In fact, more than 80% of users said an LLM gave better answers than task-specific GenAI.
However, we can't view this as a total vote of confidence in LLMs...
According to the report, only 10% of enterprise-level LLM users said they use it for complex, multiweek projects. A larger 70% said they only use LLMs for quick tasks.
These users felt that LLMs didn't respond to their feedback fast enough. LLMs learn from consuming data in huge volumes. Enterprise users can't specialize the LLMs quickly enough to turn profits.
The report also stated that every prompt also needed large amounts of context to create usable results. The time spent providing the LLM context and editing the results can offset the time savings of using AI.
However, the report says that use of AI has improved a few marketing metrics...
Companies saw a 10% improvement in customer retention when using AI.
And thanks to AI, lead qualification speed was 40% faster. Lead qualification is the process of evaluating the chance that a customer will purchase a particular product.
But the report says that organizations got better use from AI in "back office" roles.
Organizations saw faster document-processing speeds with AI. And AI reduced the fees and costs associated with outsourcing work.
Of course, investors would miss huge gains by ignoring the AI boom altogether. However, as investors, we need to be wary of every tech startup with a flashy AI product...
There's a difference between rolling out an AI product that promises big results... and the product actually achieving those results.
We must pick our AI investments carefully. It's not as simple as expecting "easy money" from AI stocks.
Good investing,
Ethan Goldman
Market View
Major Indexes and Notable Sectors
# Hld: Bullish Neutral Bearish
Dow 30
-0.17%
7
17
6
S&P 500
-0.54%
153
229
118
Nasdaq
-0.66%
30
53
17
Small Caps
-0.23%
649
978
286
Bonds
+0.7%
Energy
+1.72%
4
12
6
— According to the Chaikin Power Bar, Small Cap stocks and Large Cap stocks are Bullish. Major indexes are all bullish.
* * * *
Sector Tracker
Sector movement over the last 5 days
Information Technology
+2.88%
Utilities
+1.78%
Industrials
+0.8%
Financial
+0.37%
Health Care
+0.01%
Communication
-0.09%
Real Estate
-0.12%
Materials
-0.64%
Energy
-0.67%
Consumer Discretionary
-1.76%
Consumer Staples
-1.77%
* * * *
Industry Focus
Pharmaceuticals Services
10
25
7
Over the past 6 months, the Pharmaceuticals subsector (XPH) has underperformed the S&P 500 by -10.04%. However, its Power Bar ratio, which measures future potential, is Strong, with more Bullish than Bearish stocks. It is currently ranked #13 of 21 subsectors.
Top Stocks
ARVN
Arvinas, Inc.
AMPH
Amphastar Pharmaceut
AMRX
Amneal Pharmaceutica
* * * *
Top Movers
Gainers
HAL
+7.34%
MCK
+6.36%
TPL
+6.19%
PSKY
+6.02%
CAH
+4.85%
Losers
GNRC
-10.27%
ENPH
-7.75%
VST
-6.28%
SNPS
-4.75%
REGN
-4.67%
* * * *
Earnings Report
Earnings Surprises
MU Micron Technology, Inc.
Q4
$3.03
Beat by $0.17
AZO AutoZone, Inc.
Q4
$48.71
Missed by $-2.01
WOR Worthington Enterprises, Inc.
Q1
$0.74
Beat by $0.04
* * * *
You have received this e-mail as part of your subscription to PowerFeed. If you no longer want to receive e-mails from PowerFeed, click here.
You're receiving this e-mail at diansastroxz.forex@blogger.com.
For questions about your account or to speak with customer service, call +1 (877) 697-6783 (U.S.), 9 a.m. - 5 p.m. Eastern time or e-mail info@chaikinanalytics.com. Please note: The law prohibits us from giving personalized financial advice.
Any brokers mentioned constitute a partial list of available brokers and is for your information only. Chaikin Analytics, LLC, does not recommend or endorse any brokers, dealers, or investment advisors.
Chaikin Analytics forbids its writers from having a financial interest in any security they recommend to our subscribers. All employees of Chaikin Analytics, LLC (and affiliated companies) must wait 24 hours after an investment recommendation is published online – or 72 hours after a direct mail publication is sent – before acting on that recommendation.
This work is based on SEC filings, current events, interviews, corporate press releases, and what we've learned as financial journalists. It may contain errors, and you shouldn't make any investment decision based solely on what you read here. It's your money and your responsibility.
Post a Comment
Post a Comment